Henry Schein (HSIC), a renowned contributor in the healthcare sector, has showcased notable strength in the market, with the stock jumping 5.4%. Despite some underperformance on various days when compared to competitors, the firm's position has attracted multiple stakeholders. Investment firms like
ProShare Advisors LLC and
Intech Investment Management LLC hold substantial stakes in HSIC. Various entities including
SG Americas Securities LLC,
Mitsubishi UFJ Asset Management Co. Ltd., and
Mirae Asset Global Investments Co. Ltd. have also increased their positions. Nevertheless, several investors like
Russell Investments Group Ltd and
Swiss National Bank have reduced their holdings. Despite some sales of shares from insiders, multiple analysts uphold a 'Hold' rating for HSIC, recognizing the firm's strong value. The firm's earnings have received acknowledgment from market participants, although they were also hit by a cyberattack, inducing a measure of uncertainty.
HSIC consistently undertakes expansion activities, the latest being the acquisition of TriMed to expand in orthopedic space and a majority stake in Shield Healthcare. The company also plans to present at several investor conferences in 2024.
Henry Schein HSIC News Analytics from Sun, 15 Oct 2023 07:00:00 GMT to Sun, 21 Jul 2024 18:41:02 GMT -
Rating 4
- Innovation 7
- Information 6
- Rumor 4
